Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 35 results
Author Title [ Type(Desc)] Year
Filters: Author is Falck-Pedersen, E  [Clear All Filters]
Journal Article
Edwalds-Gilbert G, Prescott J, Falck-Pedersen E.  1993.  3' RNA processing efficiency plays a primary role in generating termination-competent RNA polymerase II elongation complexes.. Mol Cell Biol. 13(6):3472-80.
Gall J, Kass-Eisler A, Leinwand L, Falck-Pedersen E.  1996.  Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.. J Virol. 70(4):2116-23.
Yoon SO, Lois C, Alvirez M, Alvarez-Buylla A, Falck-Pedersen E, Chao MV.  1996.  Adenovirus-mediated gene delivery into neuronal precursors of the adult mouse brain.. Proc Natl Acad Sci U S A. 93(21):11974-9.
Tantravahi J, Alvira M, Falck-Pedersen E.  1993.  Characterization of the mouse beta maj globin transcription termination region: a spacing sequence is required between the poly(A) signal sequence and multiple downstream termination elements.. Mol Cell Biol. 13(1):578-87.
Kass-Eisler A, Leinwand L, Gall J, Bloom B, Falck-Pedersen E.  1996.  Circumventing the immune response to adenovirus-mediated gene therapy.. Gene Ther. 3(2):154-62.
Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, Magovern CJ, Isom OW, Rosengart T, Falck-Pedersen E et al..  1997.  Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.. Hum Gene Ther. 8(1):99-109.
Gall JG, Crystal RG, Falck-Pedersen E.  1998.  Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.. J Virol. 72(12):10260-4.
Abrahamsen K, Kong HL, Mastrangeli A, Brough D, Lizonova A, Crystal RG, Falck-Pedersen E.  1997.  Construction of an adenovirus type 7a E1A- vector.. J Virol. 71(11):8946-51.
Nicolás AL, Munz PL, Falck-Pedersen E, Young CS.  2000.  Creation and repair of specific DNA double-strand breaks in vivo following infection with adenovirus vectors expressing Saccharomyces cerevisiae HO endonuclease.. Virology. 266(1):211-24.
Wolff G, Mastrangeli A, Heinflink M, Falck-Pedersen E, Gershengorn MC, Crystal RG.  1996.  Ectopic expression of thyrotropin releasing hormone (TRH) receptors in liver modulates organ function to regulate blood glucose by TRH.. Nat Genet. 12(3):274-9.
Falck-Pedersen E, Heinflink M, Alvira M, Nussenzveig DR, Gershengorn MC.  1994.  Expression of thyrotropin-releasing hormone receptors by adenovirus-mediated gene transfer reveals that thyrotropin-releasing hormone desensitization is cell specific.. Mol Pharmacol. 45(4):684-9.
Miyazawa N, Leopold PL, Hackett NR, Ferris B, Worgall S, Falck-Pedersen E, Crystal RG.  1999.  Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.. J Virol. 73(7):6056-65.
Kass-Eisler A, Falck-Pedersen E, Elfenbein DH, Alvira M, Buttrick PM, Leinwand LA.  1994.  The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer.. Gene Ther. 1(6):395-402.
Peng Y, Trevejo J, Zhou J, Marino MW, Crystal RG, Falck-Pedersen E, Elkon KB.  1999.  Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung.. J Virol. 73(6):5098-109.
Worgall S, Wolff G, Falck-Pedersen E, Crystal RG.  1997.  Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.. Hum Gene Ther. 8(1):37-44.
Falck-Pedersen E, Neuman W, Morris PW.  1982.  Interaction of several class II and III RNA polymerases with two families of 7'-substituted alpha-amanitin.. Biochemistry. 21(21):5164-70.
Kaner RJ, Worgall S, Leopold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J et al..  1999.  Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.. Am J Respir Cell Mol Biol. 20(3):361-70.
Yeaman C, Heinflink M, Falck-Pedersen E, Rodriguez-Boulan E, Gershengorn MC.  1996.  Polarity of TRH receptors in transfected MDCK cells is independent of endocytosis signals and G protein coupling.. Am J Physiol. 270(3 Pt 1):C753-62.
Logan J, Falck-Pedersen E, Darnell JE, Shenk T.  1987.  A poly(A) addition site and a downstream termination region are required for efficient cessation of transcription by RNA polymerase II in the mouse beta maj-globin gene.. Proc Natl Acad Sci U S A. 84(23):8306-10.
Kass-Eisler A, Falck-Pedersen E, Alvira M, Rivera J, Buttrick PM, Wittenberg BA, Cipriani L, Leinwand LA.  1993.  Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo.. Proc Natl Acad Sci U S A. 90(24):11498-502.
Falck-Pedersen E, Morris PW, Venton DL.  1983.  Regiospecific arylazo substitution into alpha-amanitin with retention of inhibitory properties against eukaryotic class II RNA polymerase.. Int J Pept Protein Res. 21(4):431-9.
Gulati P, Falck-Pedersen E, Siskind GW.  1989.  Regulation of antibody secretion by hybridoma cells. II. Mechanism of idiotype-induced suppression of antibody secretion by hybridoma cells.. Cell Immunol. 123(2):276-82.
Falck-Pedersen E, Logan J.  1989.  Regulation of poly(A) site selection in adenovirus.. J Virol. 63(2):532-41.
Prescott J, Falck-Pedersen E.  1994.  Sequence elements upstream of the 3' cleavage site confer substrate strength to the adenovirus L1 and L3 polyadenylation sites.. Mol Cell Biol. 14(7):4682-93.
Prescott JC, Liu L, Falck-Pedersen E.  1997.  Sequence-mediated regulation of adenovirus gene expression by repression of mRNA accumulation.. Mol Cell Biol. 17(4):2207-16.